Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats

Fucus vesiculosus L., known as bladderwrack, belongs to the brown seaweeds, which are widely distributed throughout northern Russia, Atlantic shores of Europe, the Baltic Sea, Greenland, the Azores, the Canary Islands, and shores of the Pacific Ocean. Fucoidan is a major fucose-rich sulfated polysac...

Full description

Bibliographic Details
Main Authors: Olga N. Pozharitskaya, Alexander N. Shikov, Natalya M. Faustova, Ekaterina D. Obluchinskaya, Vera M. Kosman, Heikki Vuorela, Valery G. Makarov
Format: Article
Language:English
Published: MDPI AG 2018-04-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/16/4/132
_version_ 1828352883714686976
author Olga N. Pozharitskaya
Alexander N. Shikov
Natalya M. Faustova
Ekaterina D. Obluchinskaya
Vera M. Kosman
Heikki Vuorela
Valery G. Makarov
author_facet Olga N. Pozharitskaya
Alexander N. Shikov
Natalya M. Faustova
Ekaterina D. Obluchinskaya
Vera M. Kosman
Heikki Vuorela
Valery G. Makarov
author_sort Olga N. Pozharitskaya
collection DOAJ
description Fucus vesiculosus L., known as bladderwrack, belongs to the brown seaweeds, which are widely distributed throughout northern Russia, Atlantic shores of Europe, the Baltic Sea, Greenland, the Azores, the Canary Islands, and shores of the Pacific Ocean. Fucoidan is a major fucose-rich sulfated polysaccharide found in Fucus (F.) vesiculosus. The pharmacokinetic profiling of active compounds is essential for drug development and approval. The aim of the study was to evaluate the pharmacokinetics and tissue distribution of fucoidan in rats after a single-dose oral administration. Fucoidan was isolated from F. vesiculosus. The method of measuring anti-activated factor X (anti-Xa) activity by amidolytic assay was used to analyze the plasma and tissue concentrations of fucoidan. The tissue distribution of fucoidan after intragastric administration to the rats was characterized, and it exhibited considerable heterogeneity. Fucoidan preferentially accumulates in the kidneys (AUC0–t = 10.74 µg·h/g; Cmax = 1.23 µg/g after 5 h), spleen (AUC0–t = 6.89 µg·h/g; Cmax = 0.78 µg/g after 3 h), and liver (AUC0–t = 3.26 µg·h/g; Cmax = 0.53 µg/g after 2 h) and shows a relatively long absorption time and extended circulation in the blood, with a mean residence time (MRT) = 6.79 h. The outcome of this study provides additional scientific data for traditional use of fucoidan-containing plants and offers tangible support for the continued development of new effective pharmaceuticals using fucoidan.
first_indexed 2024-04-14T01:59:31Z
format Article
id doaj.art-eaff93a032a6469da7a4b3f5927e2136
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-14T01:59:31Z
publishDate 2018-04-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-eaff93a032a6469da7a4b3f5927e21362022-12-22T02:18:53ZengMDPI AGMarine Drugs1660-33972018-04-0116413210.3390/md16040132md16040132Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to RatsOlga N. Pozharitskaya0Alexander N. Shikov1Natalya M. Faustova2Ekaterina D. Obluchinskaya3Vera M. Kosman4Heikki Vuorela5Valery G. Makarov6Saint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaSaint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaRMC “House of Pharmacy”, Leningrad Region, Vsevolozhsky District, Zavodskaya str., 3, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaFederal State Budgetary Scientific Institution of Murmansk Marine Biological Institute, Kola Scientific Center of the Russian Academy of Sciences (MMBI KSC RAS), Vladimirskaya, 17, 183010 Murmansk, RussiaSaint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5E), University of Helsinki, FI-00014 Helsinki, FinlandSaint-Petersburg Institute of Pharmacy, Leningrad Region, Vsevolozhsky District, Kuzmolovo P 245, 188663 Saint-Petersburg, RussiaFucus vesiculosus L., known as bladderwrack, belongs to the brown seaweeds, which are widely distributed throughout northern Russia, Atlantic shores of Europe, the Baltic Sea, Greenland, the Azores, the Canary Islands, and shores of the Pacific Ocean. Fucoidan is a major fucose-rich sulfated polysaccharide found in Fucus (F.) vesiculosus. The pharmacokinetic profiling of active compounds is essential for drug development and approval. The aim of the study was to evaluate the pharmacokinetics and tissue distribution of fucoidan in rats after a single-dose oral administration. Fucoidan was isolated from F. vesiculosus. The method of measuring anti-activated factor X (anti-Xa) activity by amidolytic assay was used to analyze the plasma and tissue concentrations of fucoidan. The tissue distribution of fucoidan after intragastric administration to the rats was characterized, and it exhibited considerable heterogeneity. Fucoidan preferentially accumulates in the kidneys (AUC0–t = 10.74 µg·h/g; Cmax = 1.23 µg/g after 5 h), spleen (AUC0–t = 6.89 µg·h/g; Cmax = 0.78 µg/g after 3 h), and liver (AUC0–t = 3.26 µg·h/g; Cmax = 0.53 µg/g after 2 h) and shows a relatively long absorption time and extended circulation in the blood, with a mean residence time (MRT) = 6.79 h. The outcome of this study provides additional scientific data for traditional use of fucoidan-containing plants and offers tangible support for the continued development of new effective pharmaceuticals using fucoidan.http://www.mdpi.com/1660-3397/16/4/132anti-Xa activityFucus vesiculosusfucoidankidneysliverpharmacokineticspleen
spellingShingle Olga N. Pozharitskaya
Alexander N. Shikov
Natalya M. Faustova
Ekaterina D. Obluchinskaya
Vera M. Kosman
Heikki Vuorela
Valery G. Makarov
Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
Marine Drugs
anti-Xa activity
Fucus vesiculosus
fucoidan
kidneys
liver
pharmacokinetic
spleen
title Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
title_full Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
title_fullStr Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
title_full_unstemmed Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
title_short Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats
title_sort pharmacokinetic and tissue distribution of fucoidan from fucus vesiculosus after oral administration to rats
topic anti-Xa activity
Fucus vesiculosus
fucoidan
kidneys
liver
pharmacokinetic
spleen
url http://www.mdpi.com/1660-3397/16/4/132
work_keys_str_mv AT olganpozharitskaya pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats
AT alexandernshikov pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats
AT natalyamfaustova pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats
AT ekaterinadobluchinskaya pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats
AT veramkosman pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats
AT heikkivuorela pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats
AT valerygmakarov pharmacokineticandtissuedistributionoffucoidanfromfucusvesiculosusafteroraladministrationtorats